CClinicalTrials.gg
CompletedNCT03842293Updated Nov 27, 2020

Clinical Evaluation of PROMIS in CKD

An observational study in Chronic Kidney Diseases, sponsored by Children's Hospital of Philadelphia. Completed at 16 sites in 2 countries. Open to participants aged 8 Years to 21 Years. Per ClinicalTrials.gov, last updated 2020-11-27.

Sponsored by Children's Hospital of Philadelphia · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
213
Ages
8 Years to 21 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the clinical validity of a set of PROMIS pediatric person-reported outcome measures in patients with chronic kidney disease. The evaluation includes longitudinal assessments of how measures change in association with clinical changes.

Read the detailed description

The National Institutes of Health (NIH)-sponsored Patient-Reported Outcomes Measurement Information System (PROMIS) network has developed over 20 pediatric instruments, both child-report and parent-proxy editions. Cross-sectional evaluations of the validity of the instruments have established that they are ready for integration into clinical research and practice. The next step in their ongoing evaluation is to assess their prospective clinical validity in a variety of health conditions. This study addresses the clinical evaluation of the measures in children with chronic kidney disease (CKD).

Through baseline surveys and six follow-up surveys over a two-year period, Investigators are collecting self-report (child) and parent-proxy report of 11 pediatric PROMIS measures. Each of these PROMIS measures is described in the Main Outcome Measures section. Investigators are also collecting assessments of disease activity from clinical data. The selection of self-report and parent proxy patient-reported outcome (PRO) measures were determined through qualitative content validation. The analytic goal of this project is to evaluate baseline (cross-sectional) and longitudinal associations between PROMIS pediatric outcome measures and changes in the clinical status of patients with CKD. Our primary hypothesis is that as kidney function declines, self-reported health will worsen.

02

Conditions studied

  • Chronic Kidney Diseases
03

In context

Kidney Diseases

3,840 studies on the registry are indexed under Kidney Diseases; 500 are open to participants now.

This study's enrollment of 213 is above the median of 192 across 1,033 observational studies indexed under Kidney Diseases.

Browse Kidney Diseases studies →

Lead sponsor

Children's Hospital of Philadelphia is the lead sponsor of 480 studies on the registry; 85 are open to participants now.

Of its 28 completed or terminated interventional studies of FDA-regulated products, 22 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 21 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Participants were initially recruited through an existing study, the Chronic Kidney Disease in Children (CKiD) study. CKiD is a long-term prospective cohort study that currently follows 364 children with CKD from 54 North American centers. Recruitment was expanded to also enroll children between the ages of 8 and 21 years who had been seen at a nephrology clinic at two CKiD participating sites, Children's Hospital of Philadelphia (CHOP) and Cincinnati Children's Hospital and Medical Center (CCHMC) and had two eGFR readings (computed from serum creatinine) between 6-89 ml/min at least 3 months apart (eGFR of this level indicates CKD).

Inclusion criteria

  • Child is 8-21 years old at time of enrollment
  • Child is a Chronic Kidney Disease in Children (CKiD) patient OR a child who receives pediatric nephrology care at a CKiD site that participates in PEDSnet, a national pediatric learning health system
  • Child seen by a pediatric nephrologist in the past 24 months
  • Child has two eGFR readings (computed from serum creatinine) between 6-89 ml/min at least 3 months apart (eGFR of this level indicates CKD)
  • Child speaks English
  • Parent is the parent or legal guardian for the child
  • Parent speaks English

Exclusion criteria

Exclusion Criteria:

  • Child is currently receiving dialysis
  • Child received a kidney transplant
  • Child has a parent-reported cognitive limitation that would preclude them from completing a questionnaire
  • Child does not speak English
  • Parent does not speak English
  • Parent is not the parent of legal guardian for the child
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
213 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Longitudinal change in sleep disturbance

    Child self-report of 8 items from PROMIS sleep-related disturbance domain. Participants rate their experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population.

    Time frame: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.

  2. Longitudinal change in sleep-related impairment

    Child self-report of 4 items from PROMIS sleep-related impairment domain. Participants rate their experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population.

    Time frame: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.

  3. Longitudinal change in fatigue

    Child self-report of 8 items from PROMIS fatigue domain. Participants rate their experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population.

    Time frame: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.

  4. Longitudinal change in life satisfaction

    Child self-report of 4 items from from PROMIS life satisfaction domain. Participants rate their experience using a five point scale ranging from not at all to quite a bit. Answers are converted to a t-score to compare to the general population.

    Time frame: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.

  5. Longitudinal change in meaning and purpose

    Child self-report of 4 items from from PROMIS meaning and purpose domain. Participants rate their experience using a five point scale ranging from not at all to quite a bit. Answers are converted to a t-score to compare to the general population.

    Time frame: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.

  6. Longitudinal change in psychological stress experiences

    Child self-report of 4 items from from PROMIS psychological stress experiences domain. Participants rate their experience using a five point scale ranging from not at all to quite a bit. Answers are converted to a t-score to compare to the general population.

    Time frame: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.

  7. Longitudinal change in global health

    Parent proxy report of 7 items from from PROMIS global health domain. Parents rate their child's experience using a five point scale ranging from poor to excellent. Answers are converted to a t-score to compare to the general population.

    Time frame: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.

  8. Longitudinal change in depressive symptoms

    Parent proxy report of 4 items from from PROMIS emotional distress - depressive symptoms domain. Parents rate their child's experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population.

    Time frame: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.

  9. Longitudinal change in anxiety

    Parent proxy report of 4 items from from PROMIS emotional distress - anxiety domain. Parents rate their child's experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population.

    Time frame: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.

  10. Longitudinal change in positive affect

    Parent proxy report of 4 items from from PROMIS positive affect domain. Parents rate their child's experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population.

    Time frame: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.

  11. Longitudinal change in family relationships

    Parent proxy report of 4 items from from PROMIS family relationships domain. Parents rate their child's experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population.

    Time frame: Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.

07

Study locations

16 sites
  • Children's Hospital of Alabama
    Birmingham, Alabama 35205, United States
  • UCLA
    Los Angeles, California 90095, United States
  • Children's Healthcare of Atlanta
    Atlanta, Georgia 30322, United States
  • Riley Hospital for Children
    Indianapolis, Indiana 46202, United States
  • Johns Hopkins Children's Center
    Baltimore, Maryland 21287, United States
  • University of Michigan, Mott Hospital
    Ann Arbor, Michigan 48109, United States
  • Children's Mercy Hospital
    Kansas City, Missouri 64108, United States
  • St. Louis Children's Hospital
    Saint Louis, Missouri 63110, United States
  • Levine Children's
    Charlotte, North Carolina 28203, United States
  • Cincinnati Children's Hospital and Medical Center
    Cincinnati, Ohio 45229, United States
  • Cleveland Clinic
    Cleveland, Ohio 44195, United States
  • Nationwide Children's Hopsital
    Columbus, Ohio 43205, United States
  • Oregon Health and Science University
    Portland, Oregon 97201, United States
  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania 19104, United States
  • Seattle Children's Hospital
    Seattle, Washington 98105, United States
  • Children's Hospital Research Institute of Manitoba
    Winnipeg, Manitoba MB R3E 3P4, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 27, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03842293
Lead sponsor
Children's Hospital of Philadelphia
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Responsible party
Sponsor
First posted
Feb 15, 2019
Start date
Jun 22, 2017
Primary completion
Aug 30, 2020
Completion
Aug 30, 2020
Last update
Nov 27, 2020

Study contacts

Susan Furth, MD
principal investigator · Children's Hospital of Philadelphia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion